PCP
PCRX icon

Proficio Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Proficio Capital Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80
Closed -$3K – 1130
2019
Q2 		$3K Buy
80
+34
+74% +$1.44K ﹤0.01% 1419
2019
Q1 		$2K Buy
+46
New +$1.79K ﹤0.01% 1391

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Proficio Capital Partners's PCRX Position: Q3 2019 in Review

Proficio Capital Partners sold out of Pacira BioSciences (PCRX) in Q3 2019, closing a stake of 80 shares — an estimated $3K sold.

Proficio Capital Partners first reported a position in PCRX in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q2 2019. 211 funds tracked by Wall St. Rank hold PCRX as of Q3 2019.

  • Proficio Capital Partners reported no remaining Pacira BioSciences position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 80 Pacira BioSciences shares in Q3 2019, an estimated $3K.
  • Proficio Capital Partners first reported a position in Pacira BioSciences in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Pacira BioSciences position peaked at $3K in Q2 2019.
  • 211 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.